Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gpcon M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Catholicon Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gpcon M 1mg/500mg Tablet

DiaBetaComb 1mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. DiaBetaComb 1mg/500mg tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar response. Continued use is crucial, even with controlled blood sugar or feeling well; abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle modifications are vital for diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Gpcon M 1mg/500mg Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of Gpcon M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Gpcon M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Gpcon M 1mg/500mg Tablet with food.

Common Side effects of Gpcon M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gpcon M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Gpcon M 1mg/500mg tablets should be administered with food.

How Gpcon M 1mg/500mg Tablet works:

Each Gpcon M 1mg/500mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), both used to manage diabetes. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin lowers glucose production by the liver, slows intestinal glucose absorption, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Gpcon M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gpcon M 1mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Gpcon M 1mg/500mg tablets while breastfeeding is contraindicated due to the potential for infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gpcon M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gpcon M 1mg/500mg tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Gpcon M 1mg/500mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. A low initial dose of Gpcon M 1mg/500mg tablets is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gpcon M 1mg/500mg Tablet :

Should you forget a dose of Gpcon M 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gpcon M 1mg/500mg Tablet

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Gpcon M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gpcon M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gpcon M 1mg/500mg Tablets and seek immediate medical attention.
Gpcon M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gpcon M 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Gpcon M 1mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gpcon M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Gpcon M 1mg/500mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Gpcon M 1mg/500mg Tablet
42
MRP 49
14% off